Literature DB >> 12145237

Prevalence of insulin resistance syndrome in southwestern France and its relationship with inflammatory and hemostatic markers.

Pedro Marques-Vidal1, Elizabeth Mazoyer, Vanina Bongard, Pierre Gourdy, Jean-Bernard Ruidavets, Ludovic Drouet, Jean Ferrières.   

Abstract

OBJECTIVE: To assess the prevalence and relationships of insulin resistance syndrome (IRS) with inflammatory and hemostatic markers in a representative sample of the population of Southwestern France aged 35-64 years. RESEARCH DESIGN AND METHODS: In this cross-sectional study, data were collected from 597 men and 556 women and were assessed regarding BMI, blood pressure, total and HDL cholesterol levels, triglyceride level, glucose level, plasma insulin level, white blood cell count, fibrinogen level, factor VII level, von Willebrand factor, C-reactive protein level, soluble intercellular adhesion molecule, soluble vascular cell adhesion molecule-1, and soluble CD(14). Insulin resistance was defined by homeostasis model assessment > or =3.8.
RESULTS: Prevalence of IRS was higher in men than in women (23 vs. 12%, respectively; P < 0.001) and increased with age in both sexes (9, 24, and 34% for age groups 35-44, 45-54, and 55-64 years, respectively, for men and 4, 10, and 21% for women). After adjusting for age, alcohol consumption, tobacco smoking, and also for menopause in women, subjects (men and women) with IRS had significantly higher white blood cell count, factor VII levels, coagulating factor VII levels, and C-reactive protein levels than the other subjects. In men, further increases in soluble intercellular adhesion molecule and soluble vascular cell adhesion molecule-1 were noted, whereas in women, the differences were borderline significant. Conversely, no differences were found in fibrinogen, von Willebrand factor, and soluble CD(14) in both sexes.
CONCLUSIONS: IRS is relatively common in residents of Southwestern France and is related to a deleterious increase in hemostatic and inflammatory parameters.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12145237     DOI: 10.2337/diacare.25.8.1371

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  36 in total

1.  The operative risk factors in the metabolic syndrome: is it lipids and high BP or are there direct vascular effects of insulin resistance and obesity.

Authors:  Fabrice M A C Martens; Frank L J Visseren
Journal:  Curr Diab Rep       Date:  2007-02       Impact factor: 4.810

2.  Insulin Resistance is Associated with Higher Cerebrospinal Fluid Tau Levels in Asymptomatic APOEɛ4 Carriers.

Authors:  Erika J Starks; J Patrick O'Grady; Siobhan M Hoscheidt; Annie M Racine; Cynthia M Carlsson; Henrik Zetterberg; Kaj Blennow; Ozioma C Okonkwo; Luigi Puglielli; Sanjay Asthana; N Maritza Dowling; Carey E Gleason; Rozalyn M Anderson; Nancy J Davenport-Sis; LeAnn M DeRungs; Mark A Sager; Sterling C Johnson; Barbara B Bendlin
Journal:  J Alzheimers Dis       Date:  2015       Impact factor: 4.472

3.  Nonalcoholic Steatohepatitis and Hepatic Fibrosis in HIV-1-Monoinfected Adults With Elevated Aminotransferase Levels on Antiretroviral Therapy.

Authors:  Caryn G Morse; Mary McLaughlin; Lindsay Matthews; Michael Proschan; Francine Thomas; Ahmed M Gharib; Mones Abu-Asab; Abigail Orenstein; Ronald E Engle; Xiaojun Hu; Richard Lempicki; Colleen Hadigan; David E Kleiner; Theo Heller; Joseph A Kovacs
Journal:  Clin Infect Dis       Date:  2015-02-13       Impact factor: 9.079

4.  Sex differences in urinary biomarkers of vascular and endothelial function in HIV-infected persons receiving antiretroviral therapy.

Authors:  Michael S Boger; Aihua Bian; Ayumi Shintani; Ginger L Milne; Jason D Morrow; Husamettin Erdem; Valerie Mitchell; David W Haas; Todd Hulgan
Journal:  Antivir Ther       Date:  2011-12-14

5.  Systemic inflammation and the metabolic syndrome among middle-aged community volunteers.

Authors:  Anna L Marsland; Jeanne M McCaffery; Matthew F Muldoon; Stephen B Manuck
Journal:  Metabolism       Date:  2010-12       Impact factor: 8.694

6.  Plasma Fibrinogen in Type 2 Diabetic Patients with Metabolic Syndrome and its Relation with Ischemic Heart Disease (IHD) and Retinopathy.

Authors:  J V Mahendra; Satish D Kumar; T S Anuradha; Prashanth Talikoti; R S Nagaraj; V Vishali
Journal:  J Clin Diagn Res       Date:  2015-01-01

7.  Adherence to Mediterranean Diet and Non-Alcoholic Fatty Liver Disease: Effect on Insulin Resistance.

Authors:  Francesco Baratta; Daniele Pastori; Licia Polimeni; Tommaso Bucci; Fabrizio Ceci; Cinzia Calabrese; Ilaria Ernesti; Gaetano Pannitteri; Francesco Violi; Francesco Angelico; Maria Del Ben
Journal:  Am J Gastroenterol       Date:  2017-10-24       Impact factor: 10.864

8.  Risk factors and mechanisms of non-alcoholic steatohepatitis.

Authors:  Chantal A Rivera
Journal:  Pathophysiology       Date:  2008-07-29

9.  Cardiometabolic risk factors assessed by a finger stick dried blood spot method.

Authors:  Sanjay Kapur; Sonia Kapur; David Zava
Journal:  J Diabetes Sci Technol       Date:  2008-03

10.  Insulin resistance, haemostatic and inflammatory markers and coronary heart disease risk factors in Type 2 diabetic men with and without coronary heart disease.

Authors:  S G Wannamethee; G D O Lowe; A G Shaper; A Rumley; L Lennon; P H Whincup
Journal:  Diabetologia       Date:  2004-09-09       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.